¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"osmotic nephrosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® osmotic pressure ÇÑ±Û »ïÅõ¾Ð
¼³¸í   
  »ïÅõ¶ó´Â Çö»óÀº ÀÏÁ¤ Å©±â ÀÌÇÏÀÇ ¹°ÁúÀº Åë°ú½ÃŰ°í ±× ÀÌ»óÀÇ Å©±â¸¦ °¡Áø ¹°ÁúÀº Åë°ú ½ÃŰÁö ¸øÇϰԠÇϴ ¸·(¹ÝÅõ¸·)À» »çÀÌ¿¡ µÎ°í ¾çÂÊ¿¡ ±× ¸·À» Åõ°úÇÏÁö ¸øÇϴ ¹°ÁúÀÇ ³óµµ°¡ Â÷À̰¡ ³¯ ¶§ ¹ß»ýÇϴ °ÍÀ¸·Î ¸·À» Åë°úÇÒ ¼ö Àִ ¹°ÁúÀÌ ¸· ¾çÂÊÀÇ Åë°ú ÇÒ ¼ö ¾ø´Â ¹°ÁúÀÇ ³óµµ¸¦ °°°Ô Çϴ ¹æÇâÀ¸·Î ¿òÁ÷À̴ °ÍÀ» ¸»ÇÑ´Ù.
¿µ¹® osmotic fragility ÇÑ±Û »ïÅõ¾ÐÃë¾à¼º
¼³¸í   
  ÀûÇ÷±¸¼¼Æ÷ÀÇ »ïÅõ¾Ð Æ¯¼º º¯È­¿¡ ´ëÇÑ ¹Î°¨¼º. ÀûÇ÷±¸°¡ Àú³óµµÀÇ ³ªÆ®·ý ¿ë¾×¿¡ ³ëÃâÇϸ頼¼Æ÷¸·ÀÇ ´É·ÂÀ» ÃʰúÇÒ ¶§±îÁö ´Ù·®ÀÇ ¹°À» Èí¼öÇÏ¿© ºÎÇ®¾î¿Ã¶ó ÆÄ¿­Ç졒ʡí³óµµÀÇ ³ªÆ®·ý ¿ë¾×¿¡ ³ëÃâÇϸé ÀûÇ÷±¸ÀÇ ¼¼Æ÷³»¾×ÀÌ ºüÁ®³ª°¡ Å©±â°¡ ÁÙ¾îµé¸ç ÆÄ±«µÈ´Ù. ¿¹¿ÜÀû Ãë¾à¼ºÀ̳ª ÀúÇ×¼ºÀº Æ¯Á¤ º´ÀÇ Áø´ÜÀû ±âÁØÀÌ µÉ¼ö ÀÖ´Ù. Á¤»ó¼¼Æ÷´Â 0.39~0.45% ¼Ò±Ý¹° ¿ë¾×¿¡¼­ ¿ëÇ÷ÀÌ ½ÃÀ۵Ǹç, 37¡É(98.6¢µ)¿¡¼­ 0.30~0.33% ¼Ò±Ý ¿ë¾×¿¡ ÀûÇ÷±¸¸¦ ³ëÃâ½ÃŰ¸é ¿ëÇ÷Àº 24½Ã°£ À̳»¿¡ ¿Ï·áµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amyloid nephrosis
    ¾Æ¹Ð·ÎÀ̵åÄáÆÏÁõ, ¾Æ¹Ð·ÎÀ̵å½ÅÀåÁõ
  • cryptogenic nephrosis
    ÀẹÄáÆÏÁõ, Àẹ½ÅÀåÁõ
  • hemoglobinuric nephrosis
    Çì¸ð±Û·Îºó´¢ÄáÆÏÁõ, Ç÷»ö¼Ò´¢½ÅÀåÁõ
  • myeloma nephrosis
    °ñ¼öÁ¾ÄáÆÏÁõ, °ñ¼öÁ¾½ÅÀåÁõ
  • nephrosis
    ÄáÆÏÁõ, ½ÅÀåÁõ
  • osmotic barrier
    »ïÅõÀ庮
  • osmotic coefficient
    »ïÅõ°è¼ö
  • osmotic concentration
    »ïÅõ³óµµ
  • osmotic diuresis
    »ïÅõ¾ÐÀÌ´¢
  • osmotic diuretic
    »ïÅõ¾ÐÀÌ´¢Á¦
  • osmotic equilibrium
    »ïÅõÆòÇü
  • osmotic fragility
    »ïÅõ¾ÐÃë¾à¼º
  • osmotic fragility curve
    »ïÅõ¾ÐÃë¾à¼º°î¼±
  • osmotic fragility test
    »ïÅõ¾ÐÃë¾à¼º°Ë»ç
  • osmotic hemolysis
    »ïÅõ¿ëÇ÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephrosis
    ÄáÆÏÁõ, ½ÅÀåÁõ
  • osmotic diuresis
    »ïÅõ¼ºÀÌ´¢
  • osmotic fragility
    »ïÅõ¾ÐÃë¾à¼º
  • osmotic pressure
    »ïÅõ¾Ð
  • osmotic transfer
    »ïÅõÀüÀÌ
  • osmotic fragility test
    »ïÅõ¾ÐÃë¾à¼º°Ë»ç, »ïÅõ¾Ð¿©¸²¼º°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amyloid nephrosis
    ¾Æ¹Ð·ÎÀ̵åÄáÆÏÁõ
  • cryptogenic nephrosis
    ÀẹÄáÆÏÁõ
  • hemoglobinuric nephrosis
    Ç÷»ö¼Ò´¢ÄáÆÏÁõ
  • myeloma nephrosis
    °ñ¼öÁ¾ÄáÆÏÁõ
  • nephrosis
    ÄáÆÏÁõ, ½ÅÀåÁõ
  • toxic nephrosis
    µ¶¼ºÄáÆÏÁõ
  • osmotic barrier
    »ïÅõÀ庮
  • osmotic coefficient
    »ïÅõ°è¼ö
  • osmotic concentration
    »ïÅõ³óµµ
  • osmotic fragility curve
    »ïÅõ¾ÐÃë¾à°î¼±, »ïÅõ¾ÐÀúÇ×°î¼±
  • osmotic diuresis
    »ïÅõ¾ÐÀÌ´¢
  • osmotic diuretic
    »ïÅõ¾ÐÀÌ´¢Á¦
  • osmotic equilibrium
    »ïÅõÆòÇü
  • osmotic fragility
    »ïÅõ¾ÐÃë¾à¼º
  • osmotic hemolysis
    »ïÅõ¿ëÇ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hypo-osmotic fluid
    Àú»ïÅõ¿ë¾×(î¸ß¶÷âéÁäû)
  • amyloid nephrosis
    ¾Æ¹Ð·ÎÀ̵å½ÅÁõ(¡­ãìñø).
  • hemoglobinuric nephrosis
    Ç÷»ö¼Ò´¢¼º ½ÅÁõ.
  • hemoglobinuric nephrosis
    Ç÷»ö¼Ò´¢¼º ½ÅÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • amyloid nephrosis
    ¾Æ¹Ð·ÎÀ̵å½ÅÁõ(¡­ãìñø).
  • cryptogenic nephrosis
    Àẹ¼º ½ÅÁõ(¡­ãìñø).
  • hemoglobinuric nephrosis
    Ç÷»ö¼Ò´¢¼º ½ÅÁõ.
  • hemoglobinuric nephrosis
    Ç÷»ö¼Ò´¢¼º ½ÅÁõ
  • lipoid nephrosis
    ¸®Æ÷À̵å½ÅÁõ(¡­ãìñø), À¯ÁöÁú½ÅÁõ.
  • lipoid nephrosis
    À¯ÁöÁú ½ÅÁõ, ¹Ì¼Òº´º¯ ½ÅÁõÈıº(Ú°á³Ü»Ü¨ ãìñøý¦ÏØ)
  • lower nephron nephrosis
    ÇϺγ×ÇÁ·Ð½ÅÁõ(ù»Ý»¡­ãìñø).
  • myeloma nephrosis
    °ñ¼öÁ¾¼º ½ÅÁõ(¡­àõ ãìñø)
  • nephrosis
    ½ÅÁõ
  • nephrosis
    ½ÅÁõ(ãìñø).
  • nephrosis
    ½ÅÁõ(¡­ñø)
  • syphilitic nephrosis
    ¸Åµ¶¼º ½ÅÁõ(¡­ãìñø).
  • toxic nephrosis
    Áßµ¶¼º½ÅÁõ(¡­ãìñø)
  • bio osmotic
    »ýü³»»ïÅõ¾ÐÀÇ.
  • cold osmotic shock
    ÇÑ·©»ïÅõ¾Ð Ãæ°Ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • colloid osmotic pressure
    ÄÝ·ÎÀÌµå »ïÅõ¾Ð(ß¶÷âäâ)
  • osmotic barrier
    »ïÅõÀ庮(ß¶÷âî¡Ûú)
  • osmotic coefficient
    »ïÅõ°è¼ö(ß¶÷âÌõâ¦)
  • osmotic concentration
    »ïÅõ³óµµ(ß¶÷âÒØÓø)
  • osmotic potential
    »ïÅõ´É(ß¶÷âÒö)
  • osmotic pressure
    »ïÅõ¾Ð(ß¶÷âäâ)
  • osmotic shock
    »ïÅõ(ß¶÷â)
  • reduced osmotic pressure
    ȯ»ê »ïÅõ¾Ð(üµß©ß¶÷âäâ)
  • total osmotic pressure
    ÃÑ»ïÅõ¾Ð (õÅß¶÷âäâ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephrosis
    ½ÅÁõ
  • osmotic
    »ïÅõ¼ºÀÇ
  • osmotic pressure
    »ïÅõ¾Ð
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
COP capillary osmotic pressure; change of plaster; coefficient of performance; colloid oncotic pressure;...
LN Lesch-Nyhan [syndrome]; lipoid nephrosis; Lisch nodule; low necrosis; lupus nephritis; lymph node
Neph nephron; nephritis; nephrosis
COP i colloid osmotic pressure in interstitial fluid
COPp colloid osmotic pressure in plasma
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PAN Puromycin Aminonucleoside nephrosis
LN lipoid nephrosis
COP Colloid osmotic pressure
HOST Hypo-osmotic swelling test
HOS hypo-osmotic swelling test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • colloid osmotic pressure
    ÄÝ·ÎÀÌµå »ïÅõ¾Ð, ±³Áú »ïÅõ¾Ð
  • osmotic
    »ïÅõ¼ºÀÇ
    »ïÅõ¿¡ °üÇÑ. ¿ëÁú ºÐÀÚ¸¦ ¼±ÅÃÀûÀ¸·Î Åõ°úÇÏÁö ¸øÇÏ°Ô ÇÏ´Â ¸·¿¡ ÀÇÇØ µÎ ¿ë¾×ÀÌ ºÐ¸®µÇ¾î ÀÖÀ» ¶§. À̶§ ¿ëÁúÀº ¿ë¸Å¿¡ ¿ëÇØ·ÂÀÌ ÀÖ´Ù. ¿ëÁú ³óµµ°¡ ³ôÀº ÂÊÀ¸·Î, ¼ø¼öÇÑ ¿ë¸Å°¡ À̵¿ÇÏ´Â Çö»ó.
  • osmotic coefficient
    »ïÅõ °è¼ö
  • osmotic diarrhea
    »ïÅõ¼º ¼³»ç
  • osmotic diuretics
    »ïÅõ¼º ÀÌ´¢Á¦
  • osmotic fragility test
    »ïÅõ¾Ð Ãë¾à¼º °Ë»ç
  • osmotic lysis
    »ïÅõ¼º ¿ëÇ÷
  • osmotic regulation
    »ïÅõ¾Ð Á¶Àý
  • osmotic value
    »ïÅõ °ª
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
osmotic nephrosis Swelling of renal tubular epithelium associated with glomerular filtration of sugars and dextrose; the swelling is due to formation of cytoplasmic vesicles by pinocytosis, and is reversible, probably with no dysfunction, when produced by glucose or mannitol.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
diuretics, osmotic Diuretics that are filtered at the glomerulus and reabsorbed in the renal tubule only to a limited extent. They thus increase the amount of osmotically active solute in the urine and a corresponding increase in urine volume. These compounds also increase the osmolality of plasma, thereby increasing the diffusion of water from the intraocular and cerebrospinal fluids; they can be used for reducing the pressure and volume of these fluids.
(12 Dec 1998)
iso-osmotic <physiology> Having the same total osmotic pressure or osmolality as another fluid (ordinarily intracellular fluid); such a fluid is not isosmotic if it includes solutes that freely permeate cell membranes.
Synonym: iso-osmotic.
(05 Mar 2000)
osmotic <chemistry> Pertaining to or of the nature of osmosis (= the passage of pure solvent from a solution of lesser to one of greater solute concentration when the two solutions are separated by a membrane which selectively prevents the passage of solute molecules, but is permeable to the solvent).
(18 Nov 1997)
osmotic diuresis Diuresis due to a high concentration of osmotically active substances in the renal tubules (e.g., urea, sodium sulfate), which limit the reabsorption of water.
(05 Mar 2000)
osmotic diuretics Drugs, such as mannitol, which by their osmotic effects retain water during urine formation and thus dilute electrolytes in the urine, making resorption less efficient; they promote the elimination of water and electrolytes in the urine.
(05 Mar 2000)
osmotic fragility The susceptibility, or lack of resistance, of erythrocytes to haemolysis when exposed to increasingly hypotonic saline solutions.
(12 Dec 1998)
osmotic pressure See: osmosis. The pressure required to prevent osmotic flow across a semi permeable membrane separating two solutions of different solute concentration. Equal to the pressure that can be set up by osmotic flow in this system.
(18 Nov 1997)
osmotic shock Passage of solvent into a membrane bound structure due to osmosis, causing rupture of the membrane. A method of lysing cells or organelles.
(18 Nov 1997)
effective osmotic pressure That part of the total osmotic pressure of a solution that governs the tendency of its solvent to pass across a boundary, usually a semipermeable membrane; it is commonly represented by the product of the total osmotic pressure of the solution and the ratio (corrected for activities) of the number of dissolved particles that do not permeate the bounding membrane to the total number of particles in the solution; equivalent in meaning to tonicity; commonly expressed in equivalent units of osmolality rather than pressure per se.
(05 Mar 2000)
acute lobar nephrosis A severe but localised bacterial infection of the renal parenchyma that may produce a mass effect simulating a renal abscess.
(05 Mar 2000)
acute nephrosis Acute oliguric renal failure, especially that caused by certain poisons.
(05 Mar 2000)
amyloid nephrosis The nephrotic syndrome due to deposition of amyloid in the kidney.
See: renal amyloidosis.
(05 Mar 2000)
bile nephrosis <gastroenterology, nephrology> Acute renal failure occurring in a patient with liver failure. The exact causal relationship in unclear, but those with alcoholic cirrhosis and alcoholic hepatitis are at greatest risk.
Symptoms include decreased or absent urine production, jaundice, abdominal swelling, delirium, confusion, nausea and vomiting. Prognosis is very poor.
(27 Sep 1997)
vacuolar nephrosis Vacuolation of the epithelial cytoplasm of renal convoluted tubules in patients seriously depleted of potassium; vacuoles do not contain fat or glycogen, concentrating ability is impaired, polyuria and polydipsia are common, and pyelonephritis may develop.
Synonym: vacuolar nephrosis.
(05 Mar 2000)
cholaemic nephrosis An obsolete term for the occurrence of acute renal failure in jaundiced patients; the kidneys contain tubular casts of bile and may show tubular necrosis, but there is little evidence that jaundice or bile casts directly damage the kidneys.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephrosis
    (º´¸®)»óÇǼº ½ÅÀåÁõ
  • osmotic
    »ïÅõ(¼º)ÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á